君实生物：截至本回复日，公司尚无抗生素相关业务

Core Viewpoint - The company, Junshi Biosciences (688180.SH), confirmed that it currently does not engage in any antibiotic-related business and has no plans to disclose antibiotic management risks and opportunities in its annual or ESG reports [2]. Group 1 - An investor inquired about the company's involvement in antibiotic-related business and the absence of relevant disclosures in its annual and ESG reports [2]. - Junshi Biosciences responded on August 4, stating that as of the date of the response, it has no antibiotic-related business [2].